We are live on ! Find out more
HIM

Hillsdale Investment Management Portfolio holdings

AUM $4.39B
1-Year Est. Return 72.96%
This Fund
S&P 500
This Quarter Est. Return
+4.1%
1 Year Est. Return
+72.96%
3 Year Est. Return
+270.97%
5 Year Est. Return
+506.63%
10 Year Est. Return
+3,190.25%
AUM
$1.09B
AUM Growth
+$3.92M
Cap. Flow
+$30.1M
Cap. Flow %
2.75%
Top 10 Hldgs %
22.4%
Holding
668
New
117
Increased
253
Reduced
139
Closed
107

Top Sells

Rank Stock Value
1
EGO icon
Eldorado Gold
EGO
+$18.4M
2
CNI icon
Canadian National Railway
CNI
+$12.2M
3
BTG icon
B2Gold
BTG
+$11.7M
4
CCJ icon
Cameco
CCJ
+$8.79M
5
RCI icon
Rogers Communications
RCI
+$8.22M

Sector Composition

Rank Sector Weight
1 Technology 28.22%
2 Healthcare 13.16%
3 Financials 13%
4 Industrials 12.6%
5 Energy 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATRC icon
501
AtriCure
ATRC
$2.22B
$5.26K ﹤0.01%
120
+50
+71% +$2.44K
PSMT icon
502
Pricesmart
PSMT
$5.49B
$5.21K ﹤0.01%
70
+30
+75% +$2.32K
TNC icon
503
Tennant Co
TNC
$1.18B
$5.19K ﹤0.01%
70
+30
+75% +$2.39K
ALG icon
504
Alamo Group
ALG
$2.01B
$5.19K ﹤0.01%
30
+10
+50% +$1.79K
WTS icon
505
Watts Water Technologies
WTS
$12.9B
$5.18K ﹤0.01%
+30
New +$5.49K
CELH icon
506
Celsius Holdings
CELH
$6.99B
$5.15K ﹤0.01%
90
+30
+50% +$1.69K
KOP icon
507
Koppers
KOP
$857M
$5.14K ﹤0.01%
+130
New +$4.92K
FIX icon
508
Comfort Systems
FIX
$61.2B
$5.11K ﹤0.01%
30
+5
+20% +$877
DCPH
509
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$5.09K ﹤0.01%
400
-180
-31% -$2.48K
CBAY
510
DELISTED
Cymabay Therapeutics
CBAY
$5.07K ﹤0.01%
+340
New +$4.51K
GDRX icon
511
GoodRx Holdings
GDRX
$1.22B
$5.07K ﹤0.01%
+900
New +$6K
AKRO
512
DELISTED
Akero Therapeutics
AKRO
$5.06K ﹤0.01%
100
+20
+25% +$931
BMI icon
513
Badger Meter
BMI
$3.91B
$5.04K ﹤0.01%
35
+15
+75% +$2.37K
AMK
514
DELISTED
AssetMark Financial Holdings, Inc.
AMK
$5.02K ﹤0.01%
200
+80
+67% +$2.28K
ADMA icon
515
ADMA Biologics
ADMA
$2.19B
$5.01K ﹤0.01%
1,400
+420
+43% +$1.62K
CTLP
516
DELISTED
Cantaloupe
CTLP
$5K ﹤0.01%
800
+300
+60% +$2.2K
FN icon
517
Fabrinet
FN
$20.5B
$5K ﹤0.01%
30
+10
+50% +$1.39K
EPRT icon
518
Essential Properties Realty Trust
EPRT
$6.62B
$4.97K ﹤0.01%
230
+90
+64% +$2.15K
ZUO
519
DELISTED
Zuora, Inc.
ZUO
$4.94K ﹤0.01%
600
+300
+100% +$2.96K
FTDR icon
520
Frontdoor
FTDR
$5.89B
$4.89K ﹤0.01%
160
+60
+60% +$1.99K
ACLS icon
521
Axcelis
ACLS
$4.39B
$4.89K ﹤0.01%
30
+10
+50% +$1.76K
ITRI icon
522
Itron
ITRI
$4.49B
$4.85K ﹤0.01%
+80
New +$5.49K
KWR icon
523
Quaker Houghton
KWR
$2.91B
$4.8K ﹤0.01%
30
+10
+50% +$1.78K
TCBX icon
524
Third Coast Bancshares
TCBX
$758M
$4.79K ﹤0.01%
+280
New +$5.23K
CCBG icon
525
Capital City Bank Group
CCBG
$896M
$4.77K ﹤0.01%
160
+60
+60% +$1.86K

Similar funds

Hillsdale Investment Management's Q3 2023 Portfolio in Review

As of Q3 2023, Hillsdale Investment Management held 668 positions worth $1.09B, up 0.36% from $1.09B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Hillsdale Investment Management's Q3 2023 filing shows 117 new, 253 increased, 139 reduced and 107 closed positions. Its largest new stake was Precision Drilling: 378,703 shares worth $25.4M. The largest sale was Eldorado Gold, an estimated $18.4M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

  • Hillsdale Investment Management's largest Q3 2023 buy was Precision Drilling: 378,703 shares worth $25.4M.
  • Hillsdale Investment Management added most to TransAlta in Q3 2023, an estimated $17.5M increase.
  • Hillsdale Investment Management's biggest Q3 2023 reduction was Eldorado Gold, cutting an estimated $18.4M.
  • Hillsdale Investment Management fully exited Cameco in Q3 2023, selling an estimated $8.79M.
  • Hillsdale Investment Management's ten largest holdings make up 22% of its $1.09B portfolio in Q3 2023.
  • Hillsdale Investment Management opened 117 new positions and closed 107 in Q3 2023.
  • Hillsdale Investment Management's portfolio value rose 0.36% quarter-over-quarter to $1.09B.

Based on Hillsdale Investment Management's 13F filing for Q3 2023, filed 9 Nov 2023.